Q32 Bio, Inc. (QTTB)
12.80
-0.79
(-5.81%)
USD |
NASDAQ |
Sep 03, 16:00
12.72
-0.08
(-0.62%)
After-Hours: 07:58
Q32 Bio Research and Development Expense (TTM) : 14.35M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.35M |
| March 31, 2026 | 15.25M |
| December 31, 2025 | 19.16M |
| September 30, 2025 | 26.38M |
| June 30, 2025 | 37.18M |
| March 31, 2025 | 45.43M |
| December 31, 2024 | 48.14M |
| September 30, 2024 | 45.94M |
| June 30, 2024 | 39.05M |
| March 31, 2024 | 33.66M |
| December 31, 2023 | 31.73M |
| September 30, 2023 | 50.54M |
| June 30, 2023 | 68.93M |
| March 31, 2023 | 81.99M |
| December 31, 2022 | 98.35M |
| September 30, 2022 | 94.85M |
| June 30, 2022 | 92.98M |
| Date | Value |
|---|---|
| March 31, 2022 | 95.60M |
| December 31, 2021 | 93.08M |
| September 30, 2021 | 92.63M |
| June 30, 2021 | 89.06M |
| March 31, 2021 | 92.84M |
| December 31, 2020 | 100.39M |
| September 30, 2020 | 97.54M |
| June 30, 2020 | 102.81M |
| March 31, 2020 | 98.17M |
| December 31, 2019 | 89.40M |
| September 30, 2019 | 85.34M |
| June 30, 2019 | 73.04M |
| March 31, 2019 | 60.50M |
| December 31, 2018 | 47.96M |
| September 30, 2018 | 41.26M |
| June 30, 2018 | 32.81M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Beam Therapeutics, Inc. | 408.66M |
| Rallybio Corp. | 7.384M |
| Intellia Therapeutics, Inc. | 337.63M |
| Twist Bioscience Corp. | 71.86M |
| Revolution Medicines, Inc. | 1.287B |